Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2020, Vol. 25 ›› Issue (10): 1160-1170.doi: 10.12092/j.issn.1009-2501.2020.10.012

Previous Articles     Next Articles

Research progress of endoplasmic reticulum stress and its role in lung cancer#br#

MAO Xike1,2, YU Chenxi2,3, HUANG Tao2,3, Mao Tongjun4, WU Zhihao 2,5   

  1. 1 School of Anesthesiology, Wannan Medical College, Wuhu 241002, Anhui China
  • Received:2020-04-20 Revised:2020-09-29 Online:2020-10-26 Published:2020-11-03

Abstract: The endoplasmic reticulum (ER) is a place where secreted proteins and membrane proteins are synthesized and folded. The homeostatic environment of the endoplasmic reticulum is necessary to keep ER protein synthesis proceed smoothly. When unfolded proteins and misfolded proteins aggregate in the ER abnormally, it often leads to protein synthesis disorder and triggers endoplasmic reticulum stress (ERS). The endoplasmic reticulum can maintain the endoplasmic reticulum homeostasis and restore cellular function by inducing an unfolded protein response (UPR). However, as the ERS increasingly intensify, the continuous UPR reaction will trigger programmed cell death. There is close relationship between the tumorigenesis of lung cancer and ERS in cells. This article will introduce ERS, UPR and related pathways, and summarize their main causes and their roles in lung cancer, aiming to providing new ideas and potential therapeutic targets for basic research and clinical treatment of lung cancer. 

Key words: endoplasmic reticulum stress, unfolded protein response, pathway inhibitor, lung cancer

CLC Number: